Bicyclic compounds as allosteric SHP2 inhibitors

The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.

Saved in:
Bibliographic Details
Main Authors Koltun, Elena S, Gill, Adrian, Semko, Christopher, Tzitzilonis, Christos, Kiss, Gert, Won, Walter S, Aay, Naing, Li, Jie Jack, Jogalekar, Ash, Pitzen, Jennifer, Blank, Brian R, Wang, Gang, Mellem, Kevin, Buckl, Andreas
Format Patent
LanguageEnglish
Published 15.08.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
AbstractList The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
Author Buckl, Andreas
Wang, Gang
Tzitzilonis, Christos
Aay, Naing
Pitzen, Jennifer
Blank, Brian R
Kiss, Gert
Gill, Adrian
Li, Jie Jack
Mellem, Kevin
Jogalekar, Ash
Koltun, Elena S
Won, Walter S
Semko, Christopher
Author_xml – fullname: Koltun, Elena S
– fullname: Gill, Adrian
– fullname: Semko, Christopher
– fullname: Tzitzilonis, Christos
– fullname: Kiss, Gert
– fullname: Won, Walter S
– fullname: Aay, Naing
– fullname: Li, Jie Jack
– fullname: Jogalekar, Ash
– fullname: Pitzen, Jennifer
– fullname: Blank, Brian R
– fullname: Wang, Gang
– fullname: Mellem, Kevin
– fullname: Buckl, Andreas
BookMark eNrjYmDJy89L5WQwcMpMrkzOyUxWSM7PLcgvzUspVkgEopyc_OKS1CKgeLBHgJFCZl5GZlJmSX5RMQ8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstiXcMNTIwtDAyNDA3N3A0NCZOFQDuiS2V
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2018210770A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2018210770A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:51:06 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2018210770A13
Notes Application Number: AU20180210770
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190815&DB=EPODOC&CC=AU&NR=2018210770A1
ParticipantIDs epo_espacenet_AU2018210770A1
PublicationCentury 2000
PublicationDate 20190815
PublicationDateYYYYMMDD 2019-08-15
PublicationDate_xml – month: 08
  year: 2019
  text: 20190815
  day: 15
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies REVOLUTION MEDICINES, INC
RelatedCompanies_xml – name: REVOLUTION MEDICINES, INC
Score 3.2178578
Snippet The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Bicyclic compounds as allosteric SHP2 inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190815&DB=EPODOC&locale=&CC=AU&NR=2018210770A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXLlILSt2LXLr08DFlvFGFb0U32Npo2xULphq2I_95zSqd7GuQhJJCcBL6cfMm5ADwihmJuWLaSpTxThhkTCkVJU7iRxDy1mSZi-tGdTI1wMXxZsmUHiq0vTBMn9LsJjoiIShDvdXNeb_4fsbzGtrJ64jk2rZ-D-ciTW3aM2s0aMNlzRn4082au7LrIJOXpK_VZyG5MUx0jVzrAi7RJePDfHfJL2ewqleAUDiMcr6zPoCPKHhy729xrPTiatF_eWG3RV52D6uTJT4ICSmQITvmQKinGUhTkqYEHmvQWRpqUlx85zymLzgU8BP7cDRWcevW30tV4sSunfgndcl2KK5BEZpm2EJqaJjoSWoMLnaiDYBwVPkvTa-jvG-lmf_ctnNDe0VPpgPWhW39-iTvUtTW_b7boFzxIgiA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYqXqQWlb8Xukl4ehqw3qq5d0U72Vpo2xULphquI_96T0umeBnkICSQngS8nX3IuAPeIoZgqmi5lKc2kUUaYxKOkSVRJYprqZMBi_qPr-Yo7Hz0vyKIFxcYXpo4T-l0HR0REJYj3qj6vV_-PWFZtW7l-oDk2LR-dcGyJDTtG7ab1iWgZYzuYWTNTNE1kkqL_yvs0ZDeqKk-QK-3hJVvleLDfDe6XstpWKs4R7Ac4XlkdQ4uVXeiYm9xrXTjwmi9vrDboW5-AbOTJT4ICCtwQnOdDWgsxlqLgnhp4oAlvbjAQ8vIjpznPonMKd44dmq6EU0d_K40m8205h2fQLpclOweBZZqqMzaQ02SIhFahbMipAyMUFT5J0wvo7Rrpcnf3LXTc0JtG0yf_5QoO-T7yZ9M-6UG7-vxi16h3K3pTb9cvgXOFEw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Bicyclic+compounds+as+allosteric+SHP2+inhibitors&rft.inventor=Koltun%2C+Elena+S&rft.inventor=Gill%2C+Adrian&rft.inventor=Semko%2C+Christopher&rft.inventor=Tzitzilonis%2C+Christos&rft.inventor=Kiss%2C+Gert&rft.inventor=Won%2C+Walter+S&rft.inventor=Aay%2C+Naing&rft.inventor=Li%2C+Jie+Jack&rft.inventor=Jogalekar%2C+Ash&rft.inventor=Pitzen%2C+Jennifer&rft.inventor=Blank%2C+Brian+R&rft.inventor=Wang%2C+Gang&rft.inventor=Mellem%2C+Kevin&rft.inventor=Buckl%2C+Andreas&rft.date=2019-08-15&rft.externalDBID=A1&rft.externalDocID=AU2018210770A1